Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257

Background. Metabolic effects following combination antiretroviral therapy (cART) vary by regimen type. Changes in metabolic effects were assessed following cART in the AIDS Clinical Trials Group (ACTG) A5257 study, and correlated with plasma ritonavir trough concentrations (C(24)). Methods. Treatme...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Infect Dis
Hlavní autoři: Ofotokun, Ighovwerha, Na, Lumine H., Landovitz, Raphael J., Ribaudo, Heather J., McComsey, Grace A., Godfrey, Catherine, Aweeka, Francesca, Cohn, Susan E., Sagar, Manish, Kuritzkes, Daniel R., Brown, Todd T., Patterson, Kristine B., Para, Michael F., Leavitt, Randi Y., Villasis-Keever, Angelina, Baugh, Bryan P., Lennox, Jeffrey L., Currier, Judith S.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
HIV/AIDS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4660025/
https://ncbi.nlm.nih.gov/pubmed/25767256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ193
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky